You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

Documented positive hepatitis B (HBV) surface antigen, and/or HBV DNA prior to enrollment
Any prior exposure to HCV protease inhibitor therapy
HIV co-infection if on a protease inhibitor based regimen
Increase in creatinine of 15% or greater within one month (30 days) of the screening visit
Evidence of hepatocellular carcinoma at the time of enrollment
Liver disease caused by an etiology other than HCV
F4 or decompensated cirrhotic patients
Child Pugh class B or C
AST or ALT >350 within 6 months prior to enrollment
Albumin < 3g/dL at the time of enrollment
Platelet count < 75 at the time of enrollment
History of clinically significant allergy or adverse event with protease inhibitors
Evidence of the acquisition of HCV at the time of or after transplantation
Pregnant or breastfeeding women
Cyclosporine; St. John's Wort; Efavirenz; Phenytoin; Carbamazepine; Bosentan; HIV protease inhibitors; modafinil; ketoconazole; or rifampin use within 7 days of enrollment
Coadministration of more than 20 mg atorvastatin; 10 mg rosuvastatin; 20 mg of fluvastatin, lovastatin or simvastatin
{"Condition": ["adverse event", "decompensated cirrhotic", "hepatocellular carcinoma", "allergy", "Liver disease", "acquisition of HCV", "HIV co-infection"], "Device": [], "Drug": ["rifampin", "protease inhibitor", "HIV protease inhibitors", "atorvastatin", "Bosentan", "rosuvastatin", "Phenytoin", "lovastatin", "fluvastatin", "Efavirenz", "St. John\u0027s Wort", "protease inhibitors", "Carbamazepine", "ketoconazole", "simvastatin", "modafinil", "Cyclosporine"], "Measurement": ["creatinine", "ALT", "AST", "Albumin", "Child Pugh class", "hepatitis B surface antigen", "Platelet count", "HBV DNA"], "Mood": [], "Multiplier": [" atorvas tin;", "more than 20 mg", " atorvas tatin"], "Negation": ["other"], "Observation": ["HCV", "F4"], "Person": [], "Procedure": ["HCV protease inhibitor therapy"], "Qualifier": [], "ReferencePoint": ["enrollment", "transplantation"], "Scope": ["allergy or adverse event", "Cyclosporine; St. John\u0027s Wort; Efavirenz; Phenytoin; Carbamazepine; Bosentan; HIV protease inhibitors; modafinil; ketoconazole; or rifampin", "hepatitis B (HBV) surface antigen, and/or HBV DNA", "AST or ALT", "fluvastatin, lovastatin or simvastatin"], "Temporal": ["30 days", "at the time of or after transplantation", "within one month", "prior to enrollment", "within 6 months prior to enrollment", "within 7 days of enrollment"], "Value": ["B or C", "positive", "\u003c 75", "rease in 15% or greater wi", "\u003e350", "\u003c 3g/dL"], "Visit": []}